Annovis Cash and Equivalents USD Trend from 2010 to 2022

ANVS -  USA Stock  

USD 10.13  0.99  10.83%

Annovis Bio Cash and Equivalents USD yearly trend continues to be relatively stable with very little volatility. Cash and Equivalents USD is likely to grow to about 49.3 M this year. During the period from 2010 to 2022, Annovis Bio Cash and Equivalents USD destribution of quarterly values had r-value of  0.67 from its regression line and mean deviation of  12,184,329. Annovis Bio Operating Expenses is relatively stable at the moment as compared to the past year. Annovis Bio reported last year Operating Expenses of 14.54 Million. As of 05/28/2022, Research and Development Expense is likely to grow to about 9.1 M, while Consolidated Income is likely to drop (14.9 M).
  
Refresh
Check Annovis Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Annovis main balance sheet or income statement drivers, such as Operating Expenses of 15.7 M, Research and Development Expense of 9.1 M or Selling General and Administrative Expense of 4.8 M, as well as many exotic indicators such as Book Value per Share of 6.3, Current Ratio of 32.94 or Debt to Equity Ratio of 0.0367. Annovis financial statements analysis is a perfect complement when working with Annovis Bio Valuation or Volatility modules. It can also supplement various Annovis Bio Technical models. Please continue to the analysis of Annovis Bio Correlation against competitors.

Annovis Bio Quarterly Cash and Equivalents USD

42.67 Million

Share

Annovis Cash and Equivalents USD Breakdown

Showing smoothed Cash and Equivalents USD of Annovis Bio with missing and latest data points interpolated. Cash and Equivalents in USD; converted by US Dollar Exchange Rate.Annovis Bio's Cash and Equivalents USD historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Annovis Bio's overall financial position and show how it may be relating to other accounts over time.
Cash and Equivalents USD10 Years Trend
Increasing
Slightly volatile
 Cash and Equivalents USD 
Share
      Timeline 

Annovis Cash and Equivalents USD Regression Statistics

Arithmetic Mean 7,951,780
Geometric Mean 129,512
Coefficient Of Variation 222.61
Mean Deviation 12,184,329
Median 35,312
Standard Deviation 17,701,703
Range 49,290,947
R-Value 0.67
R-Squared 0.45
Significance 0.011887
Slope 3,054,151

Annovis Cash and Equivalents USD History

2019  1,858 
20208.1 M
202145.7 M
202249.3 M

About Annovis Bio Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Annovis Bio income statement, its balance sheet, and the statement of cash flows. Annovis Bio investors use historical funamental indicators, such as Annovis Bio's Cash and Equivalents USD, to determine how well the company is positioned to perform in the future. Although Annovis Bio investors may use each financial statement separately, they are all related. The changes in Annovis Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Annovis Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Annovis Bio Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Annovis Bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Free Cash Flow-9.1 M-9.4 M
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania. Annovis Bio operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 3 people.

Annovis Bio Investors Sentiment

The influence of Annovis Bio's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Annovis. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Annovis Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Annovis Bio's short interest history, or implied volatility extrapolated from Annovis Bio options trading.

Current Sentiment - ANVS

Annovis Bio Investor Sentiment

Macroaxis portfolio users are unresponsive in their sentiment towards investing in Annovis Bio. What is your sentiment towards investing in Annovis Bio? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Pair Trading with Annovis Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Annovis Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annovis Bio will appreciate offsetting losses from the drop in the long position's value.

Annovis Bio Pair Correlation

Correlation Analysis For Direct Indexing and Tax-loss Harvesting

The ability to find closely correlated positions to Annovis Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Annovis Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Annovis Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Annovis Bio to buy it.
The correlation of Annovis Bio is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Annovis Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Annovis Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Annovis Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to the analysis of Annovis Bio Correlation against competitors. Note that the Annovis Bio information on this page should be used as a complementary analysis to other Annovis Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Shere Portfolio module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Annovis Stock analysis

When running Annovis Bio price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Is Annovis Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Annovis Bio. If investors know Annovis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Annovis Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Annovis Bio is measured differently than its book value, which is the value of Annovis that is recorded on the company's balance sheet. Investors also form their own opinion of Annovis Bio's value that differs from its market value or its book value, called intrinsic value, which is Annovis Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Annovis Bio's market value can be influenced by many factors that don't directly affect Annovis Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Annovis Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Annovis Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Annovis Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.